Here’s a practical side-by-side overview of Dayvigo (lemborexant) and trazodone for insomnia.
What they are and how they work
- Dayvigo (lemborexant): A dual orexin receptor antagonist (DORA). It blocks wake-promoting orexin neuropeptides (OX1R and OX2R) to help you fall asleep and stay asleep.
- Trazodone: An antidepressant (serotonin antagonist and reuptake inhibitor, SARI) that’s often used off-label at lower doses to help with sleep. Its sedating effect comes from central actions including 5-HT receptor modulation and antihistamine-like effects.
Indications and typical use
- Dayvigo: Approved specifically for insomnia in adults. Aims to improve both sleep onset and sleep maintenance.
- Trazodone: Approved for depression; used off-label for insomnia, especially when there’s coexisting depression or anxiety. Often chosen when a patient could benefit from mood improvement in addition to sleep.
Typical dosing (general ranges)
- Dayvigo: Usually started at 5 mg at bedtime; can be increased to 10 mg if needed and tolerated. Maximum commonly 10 mg.
- Trazodone for sleep: Common bedtime doses range from 25 mg to 100 mg. For depression, doses are higher (often 150–400 mg/day, split or once daily). Dose is tailored to response and tolerability.
Onset and duration
- Dayvigo: Takes effect within about an hour for many people; some may notice next-day sleepiness or impairment, especially if the dose is higher or if you’re sensitive.
- Trazodone: Sleep onset can occur within 15–60 minutes; sedating effects can last into the next day, particularly with higher doses or in older adults.
Side effects and safety considerations
- Dayvigo: Commonly causes somnolence, dizziness, or headaches. Rare but important considerations include sleep-related behaviors (e.g., sleep-driving) and potential next-day impairment. Interacts with strong CYP3A4 inhibitors; caution with heavy alcohol use and other CNS depressants.
- Trazodone: Commonly causes daytime sleepiness, dizziness, dry mouth, and sometimes constipation or blurred vision. Orthostatic hypotension can occur, risk of priapism (rare but important). QT prolongation is a consideration with certain drug combinations or in patients with heart issues. Interactions with other antidepressants or QT-prolonging drugs; avoid abrupt changes in mood meds without doctor guidance.
Safety in special situations
- Elderly: Both can cause sedation and falls risk; start low and go slow. Dayvigo has specific guidance about aging populations; discuss risks with your clinician.
- Pregnancy/lactation: Dayvigo and trazodone both have considerations; consult a clinician. Trazodone is sometimes used in pregnancy for specific mood disorders, but decisions depend on individual risk/benefit.
- Liver/hepatic impairment: May affect dosing and safety for both; talk to your clinician if you have liver disease.
- Depression or mood disorders: Trazodone can help mood symptoms if present; Dayvigo does not treat mood disorders.
Which one might be better for you (quick take)
- If your primary problem is trouble staying asleep and you don’t have depression or mood issues, Dayvigo offers a targeted approach with a relatively lower risk of dependence compared with some other sleep medications.
- If you have insomnia plus depression or anxiety, or you want a generic option you may already have on hand, trazodone can be convenient and cost-effective. However, it can cause daytime sleepiness and other side effects, and its effectiveness for sleep is often modest compared with dedicated sleep meds.
Important note
- Do not mix either drug with alcohol or other CNS depressants unless your clinician says it’s safe.
- Talk with your clinician before starting, stopping, or combining these meds with other prescriptions, especially antidepressants, antipsychotics, or medications that affect the heart rhythm.
If you’d like, tell me more about your sleep pattern (onset vs maintenance), any depression or anxiety symptoms, other meds you’re taking, age, and any health conditions. I can help tailor a more specific comparison or help you prepare questions for your clinician.